Horizon Therapeutics PLC
NASDAQ:HZNP
Wall Street
Price Targets
HZNP Price Targets Summary
Horizon Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
HZNP
is 116.5 USD
.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HZNP's stock price target?
Price Target
116.5
USD
According to Wall Street analysts, the average 1-year price target for
HZNP
is 116.5 USD
.
What is Horizon Therapeutics PLC's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Horizon Therapeutics PLC's revenue is
37%.
The projected
CAGR
for the next 3 years is
11%.
What is Horizon Therapeutics PLC's Operating Income forecast?
Projected CAGR
46%
The
compound annual growth rate
of Horizon Therapeutics PLC's operating income for the next 3 years is
46%.
What is Horizon Therapeutics PLC's Net Income forecast?
Projected CAGR
44%
The
compound annual growth rate
of Horizon Therapeutics PLC's net income for the next 3 years is
44%.
You don't have any saved screeners yet
